
Contract Research Organization (CROs) Services Market Size Was Valued at USD 79.06 Billion in 2023, and is Projected to Reach USD 177.17 Billion by 2032, Growing at a CAGR of 9.38% From 2024-2032.
Contract Research Organizations (CROs) provide externalized research services to pharmaceutical, biotechnology, and medical device firms. They oversee clinical trials, perform lab services, and ensure regulatory adherence, simplifying the advancement of new drugs and medical devices.Contract Research Organizations (CROs) offer diverse services such as clinical trial management, regulatory compliance, data management, and biostatistical analysis. Pharmaceutical and biotechnology firms rely on CROs to execute intricate clinical trials and research tasks, ensuring regulatory adherence and expediting the drug development process.
They include cost efficiency, specialized expertise, and the capability to handle multiple projects concurrently. CROs optimize operations through their extensive knowledge and resources, enabling companies to concentrate on core activities like drug discovery and marketing. This collaboration reduces the time and financial burden associated with in-house research and development.The increasing complexity of clinical trials and the surge in biotech and pharmaceutical companies. Developments in personalized medicine, gene therapy, and biotechnology fuel this demand, as these fields require advanced and specialized research capabilities. The global CRO market is set to expand as more companies seek efficient and cost-effective research and development solutions.
Top Active Players
Medpace (U.S.), Laboratory Corporation of America Holdings (U.S.), IQVIA Inc (U.S.), Syneos Health (U.S.), KCR S.A. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Worldwide Clinical Trials (U.S.), Charles River Laboratories (U.S.), Microbiologics (U.S.), Parexel International (MA) Corporation (U.S.), Evotec SE (Germany), ICON plc (Ireland), PSI (Switzerland), Ergomed Group (UK), Novotech (Australia), Bioagile (India), WuXi Biologics (China), Tigermed (China), and Other Active Players.
Contract Research Organization (CROs) Services Market Segmented on the basis of Service Type, Therapeutic Areas, and End-User.
Contract Research Organization (CROs) Services Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 79.06 Bn. |
Forecast Period 2024-32 CAGR: |
9.38% |
Market Size in 2032: |
USD 177.17 Bn. |
Segments Covered: |
By Service Type |
|
|
By Therapeutic Areas |
|
||
By End-User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Contract Research Organization (CROs) Services Market by By Service Type
4.1 Contract Research Organization (CROs) Services Market Snapshot and Growth Engine
4.2 Contract Research Organization (CROs) Services Market Overview
4.3 Laboratory Services
The forecast period in the Contract Research Organization (CROs) Services Market research report is 2024-2032.
Medpace (U.S.), Laboratory Corporation of America Holdings (U.S.), IQVIA Inc (U.S.), Syneos Health (U.S.), KCR S.A. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Worldwide Clinical Trials (U.S.), Charles River Laboratories (U.S.), Microbiologics (U.S.), Parexel International (MA) Corporation (U.S.), Evotec SE (Germany), ICON plc (Ireland), PSI (Switzerland), Ergomed Group (UK), Novotech (Australia), Bioagile (India), WuXi Biologics (China), Tigermed (China), and Major Active Players.
The Contract Research Organization (CROs) Services Market is segmented into Service Type, Therapeutic Areas, End-User, and Region. By Service Type, the market is categorized into Laboratory Services, Clinical Research Services, Early-phase Development Services, Regulatory Affairs, and Consulting Services. By Therapeutic Areas, the market is categorized into Cardiovascular Diseases, Oncology, Diabetes, Respiratory Disorders, Central Nervous System Disorders, and Others. By Application, the market is categorized into Academic & Research Institutes, Medical Device Companies, and Pharmaceutical & Biotechnological Companies. By Region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Contract Research Organizations (CROs) provide externalized research services to pharmaceutical, biotechnology, and medical device firms. They oversee clinical trials, perform lab services, and ensure regulatory adherence, simplifying the advancement of new drugs and medical devices.
Contract Research Organization (CROs) Services Market Size Was Valued at USD 79.06 Billion in 2023, and is Projected to Reach USD 177.17 Billion by 2032, Growing at a CAGR of 9.38% From 2024-2032